News Room

  • December 12, 2018
    Altasciences Contributes to Positive Top-Line Phase 1 Results for Chronic Cough Drug Candidate
    Altasciences recently completed an important First-in-Human (FIH), Phase I, integrated adaptive clinical trial, including single and multiple ascending doses (SAD and MAD), Project Management, Bioanalysis, and Medical Writing, for sponsor Bellus Health.
  • November 8, 2018
    Altasciences Completes Bioanalytical Laboratory Expansion
    Altasciences is excited to announce the end of construction in their laboratory expansion.
  • October 1, 2018
    Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff
    Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington.
  • September 25, 2018
    Altasciences to present Continuing Education Course at the New York State Bar Association
    Altasciences is pleased to announce that Dr. Graham K. Wood, Chief R&D Officer at Altasciences, is presenting at a Continuing Legal Education program entitled Practical Implications of Decriminalized Marijuana for the Legal Practitioner on Wednesday, October 3.
  • September 6, 2018
    Dr. William J. Foster Joins Altasciences as Principal Investigator
    Altasciences is pleased to welcome Dr. William J. Foster, MD, PhD, FRCSC, to the Altasciences family as Principal Investigator and Consultant on clinical trials.